15 research outputs found
Functionalisation of PLLA nanofiber scaffolds using a possible cooperative effect between collagen type I and BMP-2: impact on growth and osteogenic differentiation of human mesenchymal stem cells
Mesenchymal stem cell differentiation of osteoblasts is triggered by a series of signaling processes including integrin and bone morphogenetic protein (BMP), which therefore act in a cooperative manner. The aim of this study was to analyze whether these processes can be remodeled in an artificial poly-(l)-lactide acid (PLLA) based nanofiber scaffold. Matrices composed of PLLA-collagen type I or BMP-2 incorporated PLLA-collagen type I were seeded with human mesenchymal stem cells (hMSC) and cultivated over a period of 22Ā days, either under growth or osteoinductive conditions. During the course of culture, gene expression of alkaline phosphatase (ALP), osteocalcin (OC) and collagen I (COL-I) as well as Smad5 and focal adhesion kinase (FAK), two signal transduction molecules involved in BMP-2 or integrin signaling were analyzed. Furthermore, calcium and collagen I deposition, as well as cell densities and proliferation, were determined using fluorescence microscopy. The incorporation of BMP-2 into PLLA-collagen type I nanofibers resulted in a decrease in diameter as well as pore sizes of the scaffold. Mesenchymal stem cells showed better adherence and a reduced proliferation on BMP-containing scaffolds. This was accompanied by an increase in gene expression of ALP, OC and COL-I. Furthermore the presence of BMP-2 resulted in an upregulation of FAK, while collagen had an impact on the gene expression of Smad5. Therefore these different strategies can be combined in order to enhance the osteoblast differentiation of hMSC on PLLA based nanofiber scaffold. By doing this, different signal transduction pathways seem to be up regulated
Hydrothermal liquefaction of biomass: Developments from batch to continuous process
This review describes the recent results in hydrothermal liquefaction (HTL) of biomass in continuous-flow processing systems. Although much has been published about batch reactor tests of biomass HTL, there is only limited information yet available on continuous-flow tests, which can provide a more reasonable basis for process design and scale-up for commercialization. High-moisture biomass feedstocks are the most likely to be used in HTL. These materials are described and results of their processing are discussed. Engineered systems for HTL are described; however, they are of limited size and do not yet approach a demonstration scale of operation. With the results available, process models have been developed, and mass and energy balances determined. From these models, process costs have been calculated and provide some optimism as to the commercial likelihood of the technology
Recommended from our members
TLR7 Agonism Accelerates Disease and Causes a Fatal Myeloproliferative Disorder in NZM 2410 Lupus Mice
Murine models of lupus, both spontaneous and inducible, are valuable instruments to study SLE pathogenesis. Accelerants such as Type I IFN are often used to trigger earlier disease onset. We used a topical TLR7 agonist, previously reported to induce lupus-like disease in WT mice within weeks, to validate this data in C57BL/6j mice, and to test TLR7 agonism as an accelerant in lupus-prone NZM2410 mice. We found that TLR7-stimulated B6 and NZM2410 mice had significantly reduced survival and exhibited profound splenomegaly with significantly reduced B cells (4 vs. 40%), and T cells (8 vs. 31%). Spleen pathology and IHC revealed massive expansion of F4/80+ cells in TLR7-treated mice consistent with histiocytosis. While resiqimod treatment caused mild autoimmunity in B6 mice and accelerated autoimmunity in NZM2410 mice, it did not cause significant nephritis or proteinuria in either strain (renal function intact at death). Given the macrophage expansion, cytopenias, and disruption of normal splenic lymphoid follicle architecture, histiocytic sarcoma is favored as the cause of death. An alternative etiology is a macrophage activation syndrome (MAS)-like syndrome, since the mice also had a transaminitis and histologic hemophagocytosis in the setting of their rapid mortality. For investigators who are focused on murine models of lupus nephritis, this model is not ideal when utilizing B6 mice, however topical resiqimod may prove useful to accelerate autoimmunity and nephritis in NZM2410 mice, or potentially to investigate secondary complications of lupus such as histiocytic diseases or macrophage activation like syndromes
Complete knockout of estrogen receptor alpha is not directly protective in murine lupus
Systemic lupus erythematosus (SLE) is a chronic and potentially severe autoimmune disease that disproportionately affects women. Despite a known role for hormonal factors impacting autoimmunity and disease pathogenesis, the specific mechanisms of action remain poorly understood. Our laboratory previously backcrossed āestrogen receptor alpha knockout (ERĪ±KO)ā mice onto the NZM2410 lupus prone background to generate NZM/ERĪ±KO mice. This original ERĪ±KO mouse, developed in the mid-1990s and utilized in hundreds of published studies, is not in fact ERĪ± null. They express an N-terminally truncated ERĪ±, and are considered a functional KO. They have physiologic deficiencies including infertility due to disruption of a critical activation domain (AF-1) at the N terminus of ERĪ±, required for most classic estrogen (E2) actions. We demonstrated that female NZM/ERĪ±KO mice had significantly less renal disease and significantly prolonged survival compared to WT littermates despite similar serum levels of autoantibodies and glomerular immune complex deposition. Herein, we present results of experiments using a lupus prone true ERĪ±ā/ā mice (deletional KO mice on the NZM2410 background), surprisingly finding that these animals were not protected if they were ovariectomized, suggesting that another hormonal component confers protection, possibly testosterone, rather than the absence of the full-length ERĪ±.
ā¢NZM2410 ERĪ±ā/ā mice are not protected from lupus disease expression if ovariectomized.ā¢ERĪ± disruption increases, not decreases, autoantibody production in the NZM2410 model.ā¢E2 can exacerbate lupus disease expression via a mechanism that is independent of ERĪ±.ā¢DCs & their subsets (cDC1, cDC2) are not altered by E2 or ERĪ± on the NZM background
Are Microparticles the Missing Link between Thrombosis and Autoimmune Diseases? Involvement in Selected Rheumatologic Diseases
Recommended from our members
Novel mechanism for estrogen receptor alpha modulation of murine lupus
Female sex is a risk factor for lupus. Sex hormones, sex chromosomes and hormone receptors are implicated in the pathogenic pathways in lupus. Estrogen receptor alpha (ERĪ±) knockout (KO) mice are used for defining hormone receptor effects in lupus. Prior studies of ERĪ± KO in lupus have conflicting results, likely due to sex hormone levels, different lupus strains and different ERĪ± KO constructs. Our objective was to compare a complete KO of ERĪ± vs. the original functional KO of ERĪ± (expressing a short ERĪ±) on disease expression and immune phenotype, while controlling sex hormone levels. We studied female lupus prone NZM2410 WT and ERĪ± mutant mice. All mice (nĀ =Ā 44) were ovariectomized (OVX) for hormonal control. Groups of each genotype were estrogen (E2)-repleted after OVX. We found that OVXed NZM mice expressing the truncated ERĪ± (ERĪ± short) had significantly reduced nephritis and prolonged survival compared to both wildtype and the complete ERĪ±KO (ERĪ± null) mice, but surprisingly only if E2-repleted. ERĪ± null mice were not protected regardless of E2 status. We observed significant differences in splenic B cells and dendritic cells and a decrease in cDC2 (CD11b+CD8ā) dendritic cells, without a concomitant decrease in cDC1 (CD11b-CD8a+) cells comparing ERĪ± short to ERĪ± null or WT mice. Our data support a protective role for the ERĪ± short protein. ERĪ± short is similar to an endogenously expressed ERĪ± variant (ERĪ±46). Modulating its expression/activity represents a potential approach for treating female-predominant autoimmune diseases.
ā¢NZM2410 mice expressing an ERĪ± short variant are protected from glomerulonephritis.ā¢The protective effect of ERĪ± āshortā requires estrogen, but not testosterone.ā¢B cells and dendritic cells are reduced in NZM mice expressing the ERĪ± short variant.ā¢CD8+CD11b- (cDC1s) are increased vs. CD8a-CD11b+ (cDC2s) cells in NZM ERĪ± short mice
Early ovariectomy results in reduced numbers of CD11c+/CD11b+ spleen cells and impacts disease expression in murine lupus
Ninety percent of those diagnosed with systemic lupus erythematosus (SLE) are female, with peak incidence between the ages of 15 and 45, when women are most hormonally active. Despite significant research effort, the mechanisms underlying this sex bias remain unclear. We previously showed that a functional knockout of estrogen receptor alpha (ERĪ±KO) resulted in significantly reduced renal disease and increased survival in murine lupus. Dendritic cell (DC) development, which requires both estrogen and ERĪ± is impacted, as is activation status and cytokine production. Since both estrogen and testosterone levels have immunomodulating effects, we presently studied the phenotype of NZM2410 lupus-prone mice following post-pubertal and pre-pubertal ovariectomy (OVX) +/- estradiol (E2) replacement to determine the impact of hormonal status on disease expression and DC development in these mice. We observed a trend towards survival benefit in addition to decreased proteinuria and improved renal histology in the early OVX but not late OVX or E2-repleted WT mice. Interestingly, there was a also significant difference in splenic DC subsets by flow cytometry. Spleens from NZM mice OVXād early had a significant decrease in pro-inflammatory CD11c+CD11b+ DCs (vs. unmanipulated WTs, late OVX and E2-repleted mice). These early OVXād animals also had a significant increase in tolerogenic CD11c+CD8a+ DCs vs. WT. These data join a growing body of evidence that supports a role for hormone modulation of DCs that likely impacts the penetrance and severity of autoimmune diseases such as lupus
Spinal projections of the A5, A6 (locus coeruleus), and A7 noradrenergic cell groups in rats
The pontine noradrenergic cell groups, A5, A6 (locus coeruleus), and A7, provide the only noradrenergic innervation of the spinal cord, but the individual contribution of each of these populations to the regional innervation of the spinal cord remains controversial. We used an adeno-associated viral (AAV) vector encoding green fluorescent protein under an artificial dopamine beta-hydroxylase (PRSx8) promoter to trace the spinal projections from the A5, A6, and A7 groups. Projections from all three groups travel through the spinal cord in both the lateral and ventral funiculi and in the dorsal surface of the dorsal horn, but A6 axons take predominantly the dorsal and ventral routes, whereas A5 axons take mainly a lateral and A7 axons a ventral route. The A6 group provides the densest innervation at all levels, and includes all parts of the spinal gray matter, but it is particularly dense in the dorsal horn. The A7 group provides the next most dense innervation, again including all parts of the spinal cord, but is it denser in the ventral horn. The A5 group supplies only sparse innervation to the dorsal and ventral horns and to the cervical and lumbosacral levels, but provides the densest innervation to the thoracic intermediolateral cell column, and in particular to the sympathetic preganglionic neurons. Thus, the pontine noradrenergic cell groups project in a roughly topographic and complementary fashion onto the spinal cord. The pattern of spinal projections observed suggests that the locus coeruleus might have the greatest effect on somatosensory transmission, the A7 group on motor function, and the A5 group on sympathetic function. J. Comp. Neurol. 520:19852001, 2012. (c) 2011 Wiley Periodicals, In